AI assistant
Sending…
Immunome Inc. — Director's Dealing 2021
Jun 22, 2021
32238_dirs_2021-06-21_39f58d84-680d-4344-bf6d-7fbaaf3727bd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Immunome Inc. (IMNM)
CIK: 0001472012
Period of Report: 2021-06-16
Reporting Person: PRENDERGAST FRANKLYN G (Director)
More from Immunome Inc.
Annual Report
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 24
Regulatory Filings
2026
Mar 20
Annual Report
2026
Mar 3
Earnings Release
2026
Mar 3
Major Shareholding Notification
2026
Feb 17
Director's Dealing
2025
Dec 31
Director's Dealing
2025
Dec 23
Major Shareholding Notification
2025
Dec 23